Abstract
As the resident innate immune cells of the central nervous system (CNS), microglia fulfil a critical role in maintaining tissue homeostasis and in directing and eliciting molecular responses to CNS damage. The human disease Multiple Sclerosis and animal models of inflammatory demyelination are characterized by a complex interplay between degenerative and regenerative processes, many of which are regulated and mediated by microglia. Cellular communication between microglia and other neural and immune cells is controlled to a large extent by the activity of cytokines. Here we review the role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination, highlighting their importance in potentiating cell damage, promoting neuroprotection and enhancing cellular repair in a context-dependent manner.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abbas, A. K., Murphy, K. M., & Sher, A. (1996). Functional diversity of helper T lymphocytes. Nature, 383, 787–793.
Adams, R. A., Bauer, J., Flick, M. J., Sikorski, S. L., Nuriel, T., Lassmann, H., et al. (2007). The fibrin-derived gamma377–395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. Journal of Experimental Medicine, 204, 571–582.
Adams, D. H., Hathaway, M., Shaw, J., Burnett, D., Elias, E., & Strain, A. J. (1991). Transforming growth factor-beta induces human T lymphocyte migration in vitro. Journal of Immunology, 147, 609–612.
Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J., & Gurney, A. L. (2003). Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. Journal of Biological Chemistry, 278, 1910–1914.
Akassoglou, K., Bauer, J., Kassiotis, G., Pasparakis, M., Lassmann, H., Kollias, G., et al. (1998). Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: Models for multiple sclerosis with primary oligodendrogliopathy. American Journal of Pathology, 153, 801–813.
Akira, S. (2003). Toll-like receptor signaling. Journal of Biological Chemistry, 278, 38105–38108.
Aktas, O., Prozorovski, T., & Zipp, F. (2006). Death ligands and autoimmune demyelination. Neuroscientist, 12, 305–316.
Albrecht, P. J., Dahl, J. P., Stoltzfus, O. K., Levenson, R., & Levison, S. W. (2002). Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival. Experimental Neurology, 173, 46–62.
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005). Interleukin-1 and neuronal injury. Nature Reviews Immunology, 5, 629–640.
Allione, A., Bernabei, P., Bosticardo, M., Ariotti, S., Forni, G., & Novelli, F. (1999). Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFN-gamma-independent induction of apoptosis. Journal of Immunology, 163, 4182–4191.
Aloisi, F. (2001). Immune function of microglia. Glia, 36, 165–179.
Aloisi, F., Penna, G., Cerase, J., Menendez Iglesias, B., & Adorini, L. (1997). IL-12 production by central nervous system microglia is inhibited by astrocytes. Journal of Immunology, 159, 1604–1612.
Aloisi, F., Ria, F., & Adorini, L. (2000). Regulation of T-cell responses by CNS antigen-presenting cells: Different roles for microglia and astrocytes. Immunology Today, 21, 141–147.
Andrews, T., Zhang, P., & Bhat, N. R. (1998). TNFalpha potentiates IFNgamma-induced cell death in oligodendrocyte progenitors. Journal of Neuroscience Research, 54, 574–583.
Araujo, D. M., & Cotman, C. W. (1992). Basic FGF in astroglial, microglial, and neuronal cultures: Characterization of binding sites and modulation of release by lymphokines and trophic factors. Journal of Neuroscience, 12, 1668–1678.
Arimoto, T., Choi, D. Y., Lu, X., Liu, M., Nguyen, X. V., Zheng, N., et al. (2006). Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra. Neurobiology of Aging, 28, 894–906.
Arnett, H. A., Hellendall, R. P., Matsushima, G. K., Suzuki, K., Laubach, V. E., Sherman, P., et al. (2002). The protective role of nitric oxide in a neurotoxicant-induced demyelinating model. Journal of Immunology, 168, 427–433.
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P. (2001). TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nature Neuroscience, 4, 1116–1122.
Arnett, H. A., Wang, Y., Matsushima, G. K., Suzuki, K., & Ting, J. P. (2003). Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. Journal of Neuroscience, 23, 9824–9832.
Austin, J. W., & Fehlings, M. G. (2008). Molecular mechanisms of Fas-mediated cell death in oligodendrocytes. Journal of Neurotrauma, 25, 411–426.
Back, S., Tuohy, T., Chen, H., Wallingford, N., Craig, A., Struve, J., et al. (2005). Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nature Medicine, 11, 966–972.
Baerwald, K. D., & Popko, B. (1998). Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma. Journal of Neuroscience Research, 52, 230–239.
Bai, X. F., Shi, F. D., Xiao, B. G., Li, H. L., van der Meide, P. H., & Link, H. (1997). Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA. Journal of Neuroimmunology, 80, 65–75.
Bandtlow, C. E., Meyer, M., Lindholm, D., Spranger, M., Heumann, R., & Thoenen, H. (1990). Regional and cellular codistribution of interleukin 1 beta and nerve growth factor mRNA in the adult rat brain: Possible relationship to the regulation of nerve growth factor synthesis. Journal of Cell Biology, 111, 1701–1711.
Barbara, J. A., Smith, W. B., Gamble, J. R., Van Ostade, X., Vandenabeele, P., Tavernier, J., et al. (1994). Dissociation of TNF-alpha cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-alpha mutants. EMBO Journal, 13, 843–850.
Barnett, M. H., Henderson, A. P., & Prineas, J. W. (2006). The macrophage in MS: Just a scavenger after all? Pathology and pathogenesis of the acute MS lesion. Multiple Sclerosis, 12, 121–132.
Barnett, M. H., & Prineas, J. W. (2004). Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Annals of Neurology, 55, 458–468.
Barres, B. A., Schmid, R., Sendnter, M., & Raff, M. C. (1993). Multiple extracellular signals are required for long-term oligodendrocyte survival. Development, 118, 283–295.
Basu, A., Krady, J. K., O’Malley, M., Styren, S. D., DeKosky, S. T., & Levison, S. W. (2002). The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. Journal of Neuroscience, 22, 6071–6082.
Batten, M., Li, J., Yi, S., Kljavin, N. M., Danilenko, D. M., Lucas, S., et al. (2006). Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nature Immunology, 7, 929–936.
Bauer, J., Berkenbosch, F., Van Dam, A. M., & Dijkstra, C. D. (1993). Demonstration of interleukin-1 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level. Journal of Neuroimmunology, 48, 13–21.
Baxter, A. G. (2007). The origin and application of experimental autoimmune encephalomyelitis. Nature Reviews Immunology, 7, 904–912.
Becher, B., Dodelet, V., Fedorowicz, V., & Antel, J. P. (1996). Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. Journal of Clinical Investigation, 98, 1539–1543.
Becher, B., Durell, B. G., & Noelle, R. J. (2003). IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. Journal of Clinical Investigation, 112, 1186–1191.
Becher, B., Prat, A., & Antel, J. P. (2000). Brain-immune connection: Immuno-regulatory properties of CNS-resident cells. Glia, 29, 293–304.
Beck, J., Rondot, P., Catinot, L., Falcoff, E., Kirchner, H., & Wietzerbin, J. (1988). Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? Acta Neurologica Scandinavica, 78, 318–323.
Begolka, W. S., Vanderlugt, C. L., Rahbe, S. M., & Miller, S. D. (1998). Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. Journal of Immunology, 161, 4437–4446.
Benveniste, E. N. (1998). Cytokine actions in the central nervous system. Cytokine and Growth Factor Reviews, 9, 259–275.
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., et al. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 441, 235–238.
Bettelli, E., Das, M. P., Howard, E. D., Weiner, H. L., Sobel, R. A., & Kuchroo, V. K. (1998). IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. Journal of Immunology, 161, 3299–3306.
Bezbradica, J. S., & Medzhitov, R. (2009). Integration of cytokine and heterologous receptor signaling pathways. Nature Immunology, 10, 333–339.
Binder, M., Cate, H., Prieto, A., Kemper, D., Butzkueven, H., Gresle, M., et al. (2008). Gas6 Deficiency Increases Oligodendrocyte Loss and Microglial Activation in Response to Cuprizone-Induced Demyelination. Journal of Neuroscience, 28, 5195–5206.
Bjartmar, C., Kidd, G., Mork, S., Rudick, R., & Trapp, B. D. (2000). Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Annals of Neurology, 48, 893–901.
Blakemore, W. F. (1973). Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. Journal of the Neurological Sciences, 20, 63–72.
Blakemore, W. F. (1982). Ethidium bromide induced demyelination in the spinal cord of the cat. Neuropathology and Applied Neurobiology, 8, 365–375.
Blakemore, W. F., & Patterson, R. C. (1978). Suppression of remyelination in the CNS by X-irradiation. Acta Neuropathologica, 42, 105–113.
Bo, L., Mork, S., Kong, P. A., Nyland, H., Pardo, C. A., & Trapp, B. D. (1994). Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. Journal of Neuroimmunology, 51, 135–146.
Brahmachari, S., & Pahan, K. (2009). Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. Journal of Immunology, 183, 2045–2058.
Brogi, A., Strazza, M., Melli, M., & Costantino-Ceccarini, E. (1997). Induction of intracellular ceramide by interleukin-1 beta in oligodendrocytes. Journal of Cellular Biochemistry, 66, 532–541.
Brok, H. P., van Meurs, M., Blezer, E., Schantz, A., Peritt, D., Treacy, G., et al. (2002). Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody. Journal of Immunology, 169, 6554–6563.
Bruck, W., Porada, P., Poser, S., Rieckmann, P., Hanefeld, F., Kretzschmar, H. A., et al. (1995). Monocyte/macrophage differentiation in early multiple sclerosis lesions. Annals of Neurology, 38, 788–796.
Butovsky, O., Ziv, Y., Schwartz, A., Landa, G., Talpalar, A. E., Pluchino, S., et al. (2006). Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Molecular and Cellular Neurosciences, 31, 149–160.
Butti, E., Bergami, A., Recchia, A., Brambilla, E., Del Carro, U., Amadio, S., et al. (2008). IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis. Gene Therapy, 15, 504–515.
Butzkueven, H., Emery, B., Cipriani, T., Marriott, M. P., & Kilpatrick, T. J. (2006). Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss. Glia, 53, 696–703.
Butzkueven, H., Zhang, J. G., Soilu-Hanninen, M., Hochrein, H., Chionh, F., Shipham, K. A., et al. (2002). LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nature Medicine, 8, 613–619.
Calabresi, P. A., Fields, N. S., Maloni, H. W., Hanham, A., Carlino, J., Moore, J., et al. (1998). Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS. Neurology, 51, 289–292.
Carpentier, P. A., Duncan, D. S., & Miller, S. D. (2008). Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain, Behavior, and Immunity, 22, 140–147.
Carrier, Y., Yuan, J., Kuchroo, V. K., & Weiner, H. L. (2007). Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. Journal of Immunology, 178, 179–185.
Casaccia-Bonnefil, P., Aibel, L., & Chao, M. V. (1996). Central glial and neuronal populations display differential sensitivity to ceramide-dependent cell death. Journal of Neuroscience Research, 43, 382–389.
Chabot, S., & Yong, V. W. (2000). Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: Relevance to MS. Neurology, 55, 1497–1505.
Chakraborty, G., Ziemba, S., Drivas, A., & Ledeen, R. W. (1997). Myelin contains neutral sphingomyelinase activity that is stimulated by tumor necrosis factor-alpha. Journal of Neuroscience Research, 50, 466–476.
Chan, A., Magnus, T., & Gold, R. (2001). Phagocytosis of apoptotic inflammatory cells by microglia and modulation by different cytokines: Mechanism for removal of apoptotic cells in the inflamed nervous system. Glia, 33, 87–95.
Chan, A., Seguin, R., Magnus, T., Papadimitriou, C., Toyka, K. V., Antel, J. P., et al. (2003). Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: Termination of CNS autoimmune inflammation and modulation by interferon-beta. Glia, 43, 231–242.
Chao, C. C., Molitor, T. W., & Hu, S. (1993). Neuroprotective role of IL-4 against activated microglia. Journal of Immunology, 151, 1473–1481.
Chari, D., Zhao, C., Kotter, M. R., Blakemore, W., & Franklin, R. J. (2006). Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system. Journal of Neuroscience Research, 83, 594–605.
Chen, G., & Goeddel, D. V. (2002). TNF-R1 signaling: A beautiful pathway. Science, 296, 1634–1635.
Chen, L. Z., Hochwald, G. M., Huang, C., Dakin, G., Tao, H., Cheng, C., et al. (1998). Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1. Proceedings of the National Academy of Sciences of the United States of America, 95, 12516–12521.
Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A., & Weiner, H. L. (1994). Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science, 265, 1237–1240.
Chitnis, T., Najafian, N., Benou, C., Salama, A. D., Grusby, M. J., Sayegh, M. H., et al. (2001). Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. Journal of Clinical Investigation, 108, 739–747.
Clerico, M., Contessa, G., & Durelli, L. (2007). Interferon-beta1a for the treatment of multiple sclerosis. Expert Opinion on Biological Therapy, 7, 535–542.
Constantinescu, C. S., Goodman, D. B., Hilliard, B., Wysocka, M., & Cohen, J. A. (2000). Murine macrophages stimulated with central and peripheral nervous system myelin or purified myelin proteins release inflammatory products. Neuroscience Letters, 287, 171–174.
Constantinescu, C. S., Wysocka, M., Hilliard, B., Ventura, E. S., Lavi, E., Trinchieri, G., et al. (1998). Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. Journal of Immunology, 161, 5097–5104.
Crisi, G. M., Santambrogio, L., Hochwald, G. M., Smith, S. R., Carlino, J. A., & Thorbecke, G. J. (1995). Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: Protection by transforming growth factor-beta and interleukin-10. European Journal of Immunology, 25, 3035–3040.
Cua, D. J., Hinton, D. R., & Stohlman, S. A. (1995). Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. Journal of Immunology, 155, 4052–4059.
Cua, D., Sherlock, J., Chen, Y., Murphy, C., Joyce, B., Seymour, B., et al. (2003). Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature, 421, 744–748.
D’Souza, S. D., Bonetti, B., Balasingam, V., Cashman, N. R., Barker, P. A., Troutt, A. B., et al. (1996). Multiple sclerosis: Fas signaling in oligodendrocyte cell death. Journal of Experimental Medicine, 184, 2361–2370.
da Cunha, A., & Vitkovic, L. (1992). Transforming growth factor-beta 1 (TGF-beta 1) expression and regulation in rat cortical astrocytes. Journal of Neuroimmunology, 36, 157–169.
Dal Canto, M. C., & Lipton, H. L. (1975). Primary demyelination in Theiler’s virus infection. An ultrastructural study. Laboratory Investigation, 33, 626–637.
De Groot, C. J., Montagne, L., Barten, A. D., Sminia, P., & Van Der Valk, P. (1999). Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. Journal of Neuropathology and Experimental Neurology, 58, 174–187.
de Herve, M. G., Delfraissy, J. F., & Taoufik, Y. (2001). Following direct CD40 activation, human primary microglial cells produce IL-12 p40 but not bioactive IL-12 p70. Cytokine, 14, 88–96.
De Simone, R., Ambrosini, E., Carnevale, D., Ajmone-Cat, M. A., & Minghetti, L. (2007). NGF promotes microglial migration through the activation of its high affinity receptor: Modulation by TGF-beta. Journal of Neuroimmunology, 190, 53–60.
Deckert-Schluter, M., Bluethmann, H., Kaefer, N., Rang, A., & Schluter, D. (1999). Interferon-gamma receptor-mediated but not tumor necrosis factor receptor type 1- or type 2-mediated signaling is crucial for the activation of cerebral blood vessel endothelial cells and microglia in murine Toxoplasma encephalitis. American Journal of Pathology, 154, 1549–1561.
Dendorfer, U., Oettgen, P., & Libermann, T. A. (1994). Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Molecular and Cellular Biology, 14, 4443–4454.
Dheen, S. T., Kaur, C., & Ling, E. A. (2007). Microglial activation and its implications in the brain diseases. Current Medicinal Chemistry, 14, 1189–1197.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., et al. (1986). Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. Journal of Experimental Medicine, 163, 1433–1450.
Dower, S. K., Kronheim, S. R., Hopp, T. P., Cantrell, M., Deeley, M., Gillis, S., et al. (1986). The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical. Nature, 324, 266–268.
Dower, S. K., Kronheim, S. R., March, C. J., Conlon, P. J., Hopp, T. P., Gillis, S., et al. (1985). Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. Journal of Experimental Medicine, 162, 501–515.
Dowling, P., Shang, G., Raval, S., Menonna, J., Cook, S., & Husar, W. (1996). Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. Journal of Experimental Medicine, 184, 1513–1518.
Drescher, K. M., Murray, P. D., Lin, X., Carlino, J. A., & Rodriguez, M. (2000). TGF-beta 2 reduces demyelination, virus antigen expression, and macrophage recruitment in a viral model of multiple sclerosis. Journal of Immunology, 164, 3207–3213.
Dunne, A. and O’Neill L. A. (2003) The interleukin-1 receptor/Toll-like receptor superfamily: Signal transduction during inflammation and host defense. Sci STKE 2003, re3.
Duong, T. T., Finkelman, F. D., Singh, B., & Strejan, G. H. (1994). Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. Journal of Neuroimmunology, 53, 101–107.
Duong, T. T., St Louis, J., Gilbert, J. J., Finkelman, F. D., & Strejan, G. H. (1992). Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. Journal of Neuroimmunology, 36, 105–115.
Emery, B., Cate, H. S., Marriott, M., Merson, T., Binder, M. D., Snell, C., et al. (2006). Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination. Proceedings of the National Academy of Sciences of the United States of America, 103, 7859–7864.
Erb, K. J., Ruger, B., von Brevern, M., Ryffel, B., Schimpl, A., & Rivett, K. (1997). Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. Journal of Experimental Medicine, 185, 329–339.
Fabry, Z., Topham, D. J., Fee, D., Herlein, J., Carlino, J. A., Hart, M. N., et al. (1995). TGF-beta 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. Journal of Immunology, 155, 325–332.
Falcone, M., Rajan, A. J., Bloom, B. R., & Brosnan, C. F. (1998). A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice. Journal of Immunology, 160, 4822–4830.
Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., & Neurath, M. F. (2004). Cutting edge: TGF-beta induces a regulatory phenotype in CD4 + CD25- T cells through Foxp3 induction and down-regulation of Smad7. Journal of Immunology, 172, 5149–5153.
Faria, A. M., & Weiner, H. L. (2005). Oral tolerance. Immunological Reviews, 206, 232–259.
Farina, C., Aloisi, F., & Meinl, E. (2007). Astrocytes are active players in cerebral innate immunity. Trends in Immunology, 28, 138–145.
Fassbender, K., Ragoschke, A., Rossol, S., Schwartz, A., Mielke, O., Paulig, A., et al. (1998). Increased release of interleukin-12p40 in MS: Association with intracerebral inflammation. Neurology, 51, 753–758.
Fazakerley, J. K., & Walker, R. (2003). Virus demyelination. Journal of Neurovirology, 9, 148–164.
Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., et al. (1996). Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). Journal of Immunology, 156, 5–7.
Ferguson, B., Matyszak, M. K., Esiri, M. M., & Perry, V. H. (1997). Axonal damage in acute multiple sclerosis lesions. Brain, 120(Pt 3), 393–399.
Ferrari, C. C., Depino, A. M., Prada, F., Muraro, N., Campbell, S., Podhajcer, O., et al. (2004). Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. American Journal of Pathology, 165, 1827–1837.
Fischer, H. G., Bielinsky, A. K., Nitzgen, B., Daubener, W., & Hadding, U. (1993). Functional dichotomy of mouse microglia developed in vitro: Differential effects of macrophage and granulocyte/macrophage colony-stimulating factor on cytokine secretion and antitoxoplasmic activity. Journal of Neuroimmunology, 45, 193–201.
Flowers, L. O., Johnson, H. M., Mujtaba, M. G., Ellis, M. R., Haider, S. M., & Subramaniam, P. S. (2004). Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function. Journal of Immunology, 172, 7510–7518.
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003). Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells. Nature Immunology, 4, 330–336.
Foote, A. K., & Blakemore, W. F. (2005). Inflammation stimulates remyelination in areas of chronic demyelination. Brain, 128, 528–539.
Franklin, R. J., & ffrench-Constant, C. (2008). Remyelination in the CNS: From biology to therapy. Nature Reviews Neuroscience, 9, 839–855.
Frei, K., Eugster, H. P., Bopst, M., Constantinescu, C. S., Lavi, E., & Fontana, A. (1997). Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. Journal of Experimental Medicine, 185, 2177–2182.
Frei, K., Fredrikson, S., Fontana, A., & Link, H. (1991). Interleukin-6 is elevated in plasma in multiple sclerosis. Journal of Neuroimmunology, 31, 147–153.
Friedman, W. J., Thakur, S., Seidman, L., & Rabson, A. B. (1996). Regulation of nerve growth factor mRNA by interleukin-1 in rat hippocampal astrocytes is mediated by NFkappaB. Journal of Biological Chemistry, 271, 31115–31120.
Furlan, R., Poliani, P. L., Galbiati, F., Bergami, A., Grimaldi, L. M., Comi, G., et al. (1998). Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination. Human Gene Therapy, 9, 2605–2617.
Gallo, V., & Armstrong, R. C. (2008). Myelin repair strategies: A cellular view. Current Opinion in Neurology, 21, 278–283.
Gao, X., Gillig, T. A., Ye, P., D’Ercole, A. J., Matsushima, G. K., & Popko, B. (2000). Interferon-gamma protects against cuprizone-induced demyelination. Molecular and Cellular Neurosciences, 16, 338–349.
Gaupp, S., Cannella, B., & Raine, C. S. (2008). Amelioration of experimental autoimmune encephalomyelitis in IL-4Ralpha-/- mice implicates compensatory up-regulation of Th2-type cytokines. American Journal of Pathology, 173, 119–129.
Germann, T., Gately, M. K., Schoenhaut, D. S., Lohoff, M., Mattner, F., Fischer, S., et al. (1993). Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. European Journal of Immunology, 23, 1762–1770.
Gijbels, K., Brocke, S., Abrams, J. S., & Steinman, L. (1995). Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Molecular Medicine, 1, 795–805.
Gil-Guerrero, L., Dotor, J., Huibregtse, I. L., Casares, N., Lopez-Vazquez, A. B., Rudilla, F., et al. (2008). In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1. Journal of Immunology, 181, 126–135.
Giulian, D., Johnson, B., Krebs, J. F., George, J. K., & Tapscott, M. (1991). Microglial mitogens are produced in the developing and injured mammalian brain. Journal of Cell Biology, 112, 323–333.
Giulian, D., & Lachman, L. B. (1985). Interleukin-1 stimulation of astroglial proliferation after brain injury. Science, 228, 497–499.
Gold, R. (2006). Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain, 129, 1953–1971.
Gough, D. J., Levy, D. E., Johnstone, R. W., & Clarke, C. J. (2008). IFNgamma signaling-does it mean JAK-STAT? Cytokine and Growth Factor Reviews, 19, 383–394.
Gran, B., Zhang, G. X., Yu, S., Li, J., Chen, X. H., Ventura, E. S., et al. (2002). IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: Evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. Journal of Immunology, 169, 7104–7110.
Greenfeder, S. A., Nunes, P., Kwee, L., Labow, M., Chizzonite, R. A., & Ju, G. (1995). Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. Journal of Biological Chemistry, 270, 13757–13765.
Grommes, C., Lee, C. Y., Wilkinson, B. L., Jiang, Q., Koenigsknecht-Talboo, J. L., Varnum, B., et al. (2008). Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases. Journal of Neuroimmune Pharmacology, 3, 130–140.
Guha, M., & Mackman, N. (2001). LPS induction of gene expression in human monocytes. Cellular Signalling, 13, 85–94.
Guo, B., Chang, E., & Cheng, G. (2008). The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. Journal of Clinical Investigation, 118, 1680–1690.
Haak, S., Croxford, A. L., Kreymborg, K., Heppner, F. L., Pouly, S., Becher, B., et al. (2009). IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. Journal of Clinical Investigation, 119, 61–69.
Hall, S. M. (1972). The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. Journal of Cell Science, 10, 535–546.
Hallenbeck, J. M. (2002). The many faces of tumor necrosis factor in stroke. Nature Medicine, 8, 1363–1368.
Hauser, S. L., Doolittle, T. H., Lincoln, R., Brown, R. H., & Dinarello, C. A. (1990). Cytokine accumulations in CSF of multiple sclerosis patients: Frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology, 40, 1735–1739.
Healy, A. M., Schwartz, J. J., Zhu, X., Herrick, B. E., Varnum, B., & Farber, H. W. (2001). Gas 6 promotes Axl-mediated survival in pulmonary endothelial cells. American Journal of Physiology Lung Cellular and Molecular Physiology, 280, L1273–L1281.
Hebenstreit, D., Wirnsberger, G., Horejs-Hoeck, J., & Duschl, A. (2006). Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine and Growth Factor Reviews, 17, 173–188.
Heine, S., Ebnet, J., Maysami, S., & Stangel, M. (2006). Effects of interferon-beta on oligodendroglial cells. Journal of Neuroimmunology, 177, 173–180.
Held, W., Meyermann, R., Qin, Y., & Mueller, C. (1993). Perforin and tumor necrosis factor alpha in the pathogenesis of experimental allergic encephalomyelitis: Comparison of autoantigen induced and transferred disease in Lewis rats. Journal of Autoimmunity, 6, 311–322.
Hemmi, S., Böhln, R., Stark, G., Di Marco, F., & Aguet, M. (1994). A novel member of the interferon receptor family complements functionality of the murine interferon γ receptor in human cells. Cell, 76, 803–810.
Hendriks, J. J., Slaets, H., Carmans, S., de Vries, H. E., Dijkstra, C. D., Stinissen, P., et al. (2008). Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. Journal of Neuroimmunology, 204, 52–57.
Hendriks, J. J., Teunissen, C. E., de Vries, H. E., & Dijkstra, C. D. (2005). Macrophages and neurodegeneration. Brain Research. Brain Research Reviews, 48, 185–195.
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hovelmeyer, N., et al. (2005). Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nature Medicine, 11, 146–152.
Herrera-Molina, R., & von Bernhardi, R. (2005). Transforming growth factor-beta 1 produced by hippocampal cells modulates microglial reactivity in culture. Neurobiology of Diseases, 19, 229–236.
Hershkoviz, R., Mor, F., Gilat, D., Cohen, I. R., & Lider, O. (1992). T cells in the spinal cord in experimental autoimmune encephalomyelitis are matrix adherent and secrete tumor necrosis factor alpha. Journal of Neuroimmunology, 37, 161–166.
Heyen, J. R., Ye, S., Finck, B. N., & Johnson, R. W. (2000). Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain Research. Molecular Brain Research, 77, 138–147.
Hinks, G. L., & Franklin, R. J. (1999). Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Molecular and Cellular Neurosciences, 14, 153–168.
Hinks, G. L., & Franklin, R. J. (2000). Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats. Molecular and Cellular Neurosciences, 16, 542–556.
Hiscott, J., Marois, J., Garoufalis, J., D’Addario, M., Roulston, A., Kwan, I., et al. (1993). Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: Evidence for a positive autoregulatory loop. Molecular and Cellular Biology, 13, 6231–6240.
Hoehn, H. J., Kress, Y., Sohn, A., Brosnan, C. F., Bourdon, S., & Shafit-Zagardo, B. (2008). Axl-/- mice have delayed recovery and prolonged axonal damage following cuprizone toxicity. Brain Research, 1240, 1–11.
Hofman, F. M., Hinton, D. R., Johnson, K., & Merrill, J. E. (1989). Tumor necrosis factor identified in multiple sclerosis brain. Journal of Experimental Medicine, 170, 607–612.
Hofman, F. M., von Hanwehr, R. I., Dinarello, C. A., Mizel, S. B., Hinton, D., & Merrill, J. E. (1986). Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. Journal of Immunology, 136, 3239–3245.
Hori, S., Nomura, T., & Sakaguchi, S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, 1057–1061.
Horvath, C. M. (2004) The Jak-STAT pathway stimulated by interferon gamma. Sci STKE 2004, tr8.
Hoshino, K., Kaisho, T., Iwabe, T., Takeuchi, O., & Akira, S. (2002). Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. International Immunology, 14, 1225–1231.
Hövelmeyer, N., Hao, Z., Kranidioti, K., Kassiotis, G., Buch, T., Frommer, F., et al. (2005). Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. Journal of Immunology, 175, 5875–5884.
Hsieh, J. (2004). IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes. Journal of Cell Biology, 164, 111–122.
Huber, M., Steinwald, V., Guralnik, A., Brustle, A., Kleemann, P., Rosenplanter, C., et al. (2008). IL-27 inhibits the development of regulatory T cells via STAT3. International Immunology, 20, 223–234.
Hunter, C. A. (2005). New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nature Reviews Immunology, 5, 521–531.
Ichijo, H. (1999). From receptors to stress-activated MAP kinases. Oncogene, 18, 6087–6093.
Ichikawa, M., Koh, C. S., Inoue, A., Tsuyusaki, J., Yamazaki, M., Inaba, Y., et al. (2000). Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing–remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide. Journal of Neuroimmunology, 102, 56–66.
Ihle, J. N. (1995). Cytokine receptor signalling. Nature, 377, 591–594.
Irvine, K., & Blakemore, W. (2008). Remyelination protects axons from demyelination-associated axon degeneration. Brain, 131, 1464–1477.
Issazadeh, S., Ljungdahl, A., Hojeberg, B., Mustafa, M., & Olsson, T. (1995). Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: Dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta. Journal of Neuroimmunology, 61, 205–212.
Jana, M., Dasgupta, S., Pal, U., & Pahan, K. (2009). IL-12 p40 homodimer, the so-called biologically inactive molecule, induces nitric oxide synthase in microglia via IL-12R beta 1. Glia, 57, 1553–1565.
Jana, M., Dasgupta, S., Saha, R. N., Liu, X., & Pahan, K. (2003). Induction of tumor necrosis factor-alpha (TNF-alpha) by interleukin-12 p40 monomer and homodimer in microglia and macrophages. Journal of Neurochemistry, 86, 519–528.
Jana, M., Liu, X., Koka, S., Ghosh, S., Petro, T. M., & Pahan, K. (2001). Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. Journal of Biological Chemistry, 276, 44527–44533.
Jana, M., & Pahan, K. (2009a). IL-12 p40 homodimer, but not IL-12 p70, induces the expression of IL-16 in microglia and macrophages. Molecular Immunology, 46, 773–783.
Jana, M., & Pahan, K. (2009b). Induction of lymphotoxin-alpha by interleukin-12 p40 homodimer, the so-called biologically inactive molecule, but not IL-12 p70. Immunology, 127, 312–325.
Jander, S., Pohl, J., D’Urso, D., Gillen, C., & Stoll, G. (1998). Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system. American Journal of Pathology, 152, 975–982.
Jang, S., Kelley, K. W., & Johnson, R. W. (2008). Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proceedings of the National Academy of Sciences of the United States of America, 105, 7534–7539.
Jeohn, G. H., Kong, L. Y., Wilson, B., Hudson, P., & Hong, J. S. (1998). Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. Journal of Neuroimmunology, 85, 1–10.
Jin, Y. H., Mohindru, M., Kang, M. H., Fuller, A. C., Kang, B., Gallo, D., et al. (2007). Differential virus replication, cytokine production, and antigen-presenting function by microglia from susceptible and resistant mice infected with Theiler’s virus. Journal of Virology, 81, 11690–11702.
John, G. R., Shankar, S. L., Shafit-Zagardo, B., Massimi, A., Lee, S. C., Raine, C. S., et al. (2002). Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nature Medicine, 8, 1115–1121.
Johns, L. D., Flanders, K. C., Ranges, G. E., & Sriram, S. (1991). Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. Journal of Immunology, 147, 1792–1796.
Johns, L. D., & Sriram, S. (1993). Experimental allergic encephalomyelitis: Neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease. Journal of Neuroimmunology, 47, 1–7.
Josefowicz, S. Z., & Rudensky, A. (2009). Control of regulatory T cell lineage commitment and maintenance. Immunity, 30, 616–625.
Kamiya, S., Owaki, T., Morishima, N., Fukai, F., Mizuguchi, J., & Yoshimoto, T. (2004). An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4 + T cells. Journal of Immunology, 173, 3871–3877.
Katz-Levy, Y., Neville, K. L., Padilla, J., Rahbe, S., Begolka, W. S., Girvin, A. M., et al. (2000). Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler’s virus-infected mice. Journal of Immunology, 165, 5304–5314.
Kawanokuchi, J., Mizuno, T., Kato, H., Mitsuma, N., & Suzumura, A. (2004). Effects of interferon-beta on microglial functions as inflammatory and antigen presenting cells in the central nervous system. Neuropharmacology, 46, 734–742.
Kawanokuchi, J., Shimizu, K., Nitta, A., Yamada, K., Mizuno, T., Takeuchi, H., et al. (2008). Production and functions of IL-17 in microglia. Journal of Neuroimmunology, 194, 54–61.
Keating, P., O’Sullivan, D., Tierney, J. B., Kenwright, D., Miromoeini, S., Mawasse, L., et al. (2009). Protection from EAE by IL-4Ralpha(-/-) macrophages depends upon T regulatory cell involvement. Immunology and Cell Biology, 87, 534–545.
Kennedy, M. K., Torrance, D. S., Picha, K. S., & Mohler, K. M. (1992). Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. Journal of Immunology, 149, 2496–2505.
Kerr, B. J., & Patterson, P. H. (2005). Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury. Glia, 51, 73–79.
Kiefer, R., Schweitzer, T., Jung, S., Toyka, K. V., & Hartung, H. P. (1998). Sequential expression of transforming growth factor-beta1 by T-cells, macrophages, and microglia in rat spinal cord during autoimmune inflammation. Journal of Neuropathology and Experimental Neurology, 57, 385–395.
Kim, B. S., Palma, J. P., Kwon, D., & Fuller, A. C. (2005). Innate immune response induced by Theiler’s murine encephalomyelitis virus infection. Immunologic Research, 31, 1–12.
Kirwin, S. J., Dowdell, K. C., Hindinger, C., Feng, N., Bergmann, C. C., Hinton, D. R., et al. (2006). Altered neuroantigen-specific cytokine secretion in a Th2 environment reduces experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 178, 30–39.
Kohji, T., & Matsumoto, Y. (2000). Coexpression of Fas/FasL and Bax on brain and infiltrating T cells in the central nervous system is closely associated with apoptotic cell death during autoimmune encephalomyelitis. Journal of Neuroimmunology, 106, 165–171.
Kohm, A. P., Carpentier, P. A., Anger, H. A., & Miller, S. D. (2002). Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. Journal of Immunology, 169, 4712–4716.
Koizumi, S., Shigemoto-Mogami, Y., Nasu-Tada, K., Shinozaki, Y., Ohsawa, K., Tsuda, M., et al. (2007). UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature, 446, 1091–1095.
Korner, H., Goodsall, A. L., Lemckert, F. A., Scallon, B. J., Ghrayeb, J., Ford, A. L., et al. (1995). Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America, 92, 11066–11070.
Kotter, M. R., Li, W. W., Zhao, C., & Franklin, R. J. (2006). Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. Journal of Neuroscience, 26, 328–332.
Kotter, M. R., Setzu, A., Sim, F. J., Van Rooijen, N., & Franklin, R. J. (2001). Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia, 35, 204–212.
Kotter, M. R., Zhao, C., van Rooijen, N., & Franklin, R. J. (2005). Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiology of Diseases, 18, 166–175.
Krady, J. K., Lin, H. W., Liberto, C. M., Basu, A., Kremlev, S. G., & Levison, S. W. (2008). Ciliary neurotrophic factor and interleukin-6 differentially activate microglia. Journal of Neuroscience Research, 86, 1538–1547.
Krakowski, M., & Owens, T. (1996). Interferon-gamma confers resistance to experimental allergic encephalomyelitis. European Journal of Immunology, 26, 1641–1646.
Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V., & Segal, B. M. (2008). IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. Journal of Experimental Medicine, 205, 1535–1541.
Kuroda, Y., & Shimamoto, Y. (1991). Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats. Journal of Neuroimmunology, 34, 159–164.
Kuruvilla, A. P., Shah, R., Hochwald, G. M., Liggitt, H. D., Palladino, M. A., & Thorbecke, G. J. (1991). Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proceedings of the National Academy of Sciences of the United States of America, 88, 2918–2921.
Kwidzinski, E., Bunse, J., Aktas, O., Richter, D., Mutlu, L., Zipp, F., et al. (2005). Indolamine 2, 3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. The FASEB Journal, 19, 1347–1349.
Kwidzinski, E., Bunse, J., Kovac, A. D., Ullrich, O., Zipp, F., Nitsch, R., et al. (2003). IDO (indolamine 2, 3-dioxygenase) expression and function in the CNS. Advances in Experimental Medicine and Biology, 527, 113–118.
Labow, M., Shuster, D., Zetterstrom, M., Nunes, P., Terry, R., Cullinan, E. B., et al. (1997). Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. Journal of Immunology, 159, 2452–2461.
Lalancette-Hebert, M., Gowing, G., Simard, A., Weng, Y. C., & Kriz, J. (2007). Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. Journal of Neuroscience, 27, 2596–2605.
Lalive, P. H., Paglinawan, R., Biollaz, G., Kappos, E. A., Leone, D. P., Malipiero, U., et al. (2005). TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. European Journal of Immunology, 35, 727–737.
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., et al. (2005). IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. Journal of Experimental Medicine, 201, 233–240.
Langrish, C. L., McKenzie, B. S., Wilson, N. J., de Waal Malefyt, R., Kastelein, R. A., & Cua, D. J. (2004). IL-12 and IL-23: Master regulators of innate and adaptive immunity. Immunological Reviews, 202, 96–105.
Lassmann, H. (2008). Mechanisms of inflammation induced tissue injury in multiple sclerosis. Journal of the Neurological Sciences, 274, 45–47.
Lassmann, H., Bruck, W., Lucchinetti, C., & Rodriguez, M. (1997). Remyelination in multiple sclerosis. Multiple Sclerosis, 3, 133–136.
Ledeboer, A., Breve, J. J., Poole, S., Tilders, F. J., & Van Dam, A. M. (2000). Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glia, 30, 134–142.
Ledeboer, A., Breve, J. J., Wierinckx, A., van der Jagt, S., Bristow, A. F., Leysen, J. E., et al. (2002). Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells. European Journal of Neuroscience, 16, 1175–1185.
Lee, W. P., Liao, Y., Robinson, D., Kung, H. J., Liu, E. T., & Hung, M. C. (1999). Axl-gas6 interaction counteracts E1A-mediated cell growth suppression and proapoptotic activity. Molecular and Cellular Biology, 19, 8075–8082.
Leonard, J. P., Waldburger, K. E., & Goldman, S. J. (1995). Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. Journal of Experimental Medicine, 181, 381–386.
Li, J., Baud, O., Vartanian, T., Volpe, J. J., & Rosenberg, P. A. (2005a). Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proceedings of the National Academy of Sciences of the United States of America, 102, 9936–9941.
Li, Y., Chu, N., Hu, A., Gran, B., Rostami, A., & Zhang, G. X. (2007). Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia. Brain, 130, 490–501.
Li, Y., Chu, N., Rostami, A., & Zhang, G. X. (2006a). Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. Journal of Immunology, 177, 1679–1688.
Li, J., Gran, B., Zhang, G. X., Rostami, A., & Kamoun, M. (2005b). IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. Journal of the Neurological Sciences, 232, 3–9.
Li, W., Maeda, Y., Ming, X., Cook, S., Chapin, J., Husar, W., et al. (2002). Apoptotic death following Fas activation in human oligodendrocyte hybrid cultures. Journal of Neuroscience Research, 69, 189–196.
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K., & Flavell, R. A. (2006b). Transforming growth factor-beta regulation of immune responses. Annual Review of Immunology, 24, 99–146.
Li, M., Zhou, Y., Feng, G., & Su, S. B. (2009). The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases. Current Molecular Medicine, 9, 365–374.
Lin, W., Kemper, A., Dupree, J. L., Harding, H. P., Ron, D., & Popko, B. (2006). Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain, 129, 1306–1318.
Lin, H. W., & Levison, S. W. (2009). Context-dependent IL-6 potentiation of interferon- gamma-induced IL-12 secretion and CD40 expression in murine microglia. Journal of Neurochemistry, 111, 808–818.
Lin, M. W., Tsao, L. T., Chang, L. C., Chen, Y. L., Huang, L. J., Kuo, S. C., et al. (2007). Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway. Biochemical Pharmacology, 73, 1796–1806.
Lipton, H. L. (1975). Theiler’s virus infection in mice: An unusual biphasic disease process leading to demyelination. Infection and Immunity, 11, 1147–1155.
Lipton, H. L., Kumar, A. S., & Trottier, M. (2005). Theiler’s virus persistence in the central nervous system of mice is associated with continuous viral replication and a difference in outcome of infection of infiltrating macrophages versus oligodendrocytes. Virus Research, 111, 214–223.
Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., et al. (1998). TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nature Medicine, 4, 78–83.
Liu, Y., Teige, I., Ericsson, I., Navikas, V., and Issazadeh-Navikas, S. (2010) Suppression of EAE by oral tolerance is independent of endogenous IFN-beta whereas treatment with recombinant IFN-beta ameliorates EAE. Immunol Cell Biol. Jan 12 (Epub ahead of print).
Lodge, P. A., & Sriram, S. (1996). Regulation of microglial activation by TGF-beta, IL-10, and CSF-1. Journal of Leukocyte Biology, 60, 502–508.
Longbrake, E. E., & Racke, M. K. (2009). Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis? Expert Review of Neurotherapeutics, 9, 319–321.
Loughlin, A. J., Woodroofe, M. N., & Cuzner, M. L. (1993). Modulation of interferon-gamma-induced major histocompatibility complex class II and Fc receptor expression on isolated microglia by transforming growth factor-beta 1, interleukin-4, noradrenaline and glucocorticoids. Immunology, 79, 125–130.
Louis, J. C., Magal, E., Takayama, S., & Varon, S. (1993). CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science, 259, 689–692.
Lovas, G., Szilagyi, N., Majtenyi, K., Palkovits, M., & Komoly, S. (2000). Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain, 123(Pt 2), 308–317.
Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W., et al. (1993). Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proceedings of the National Academy of Sciences of the United States of America, 90, 9730–9734.
Lucas, S., Ghilardi, N., Li, J., & de Sauvage, F. J. (2003). IL-27 regulates IL-12 responsiveness of naive CD4 + T cells through Stat1-dependent and -independent mechanisms. Proceedings of the National Academy of Sciences of the United States of America, 100, 15047–15052.
Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., & Lassmann, H. (1999). A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain, 122(Pt 12), 2279–2295.
Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., & Lassmann, H. (2000). Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Annals of Neurology, 47, 707–717.
Lucchinetti, C. F., Bruck, W., Rodriguez, M., & Lassmann, H. (1996). Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathology, 6, 259–274.
Luo, J., Ho, P. P., Buckwalter, M. S., Hsu, T., Lee, L. Y., Zhang, H., et al. (2007). Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis. Journal of Clinical Investigation, 117, 3306–3315.
Magnus, T., Chan, A., Linker, R. A., Toyka, K. V., & Gold, R. (2002a). Astrocytes are less efficient in the removal of apoptotic lymphocytes than microglia cells: Implications for the role of glial cells in the inflamed central nervous system. Journal of Neuropathology and Experimental Neurology, 61, 760–766.
Magnus, T., Chan, A., Savill, J., Toyka, K. V., & Gold, R. (2002b). Phagocytotic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications. Journal of Neuroimmunology, 130, 1–9.
Maimone, D., Gregory, S., Arnason, B. G., & Reder, A. T. (1991). Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. Journal of Neuroimmunology, 32, 67–74.
Maimone, D., Guazzi, G. C., & Annunziata, P. (1997). IL-6 detection in multiple sclerosis brain. Journal of the Neurological Sciences, 146, 59–65.
Makwana, M., Jones, L. L., Cuthill, D., Heuer, H., Bohatschek, M., Hristova, M., et al. (2007). Endogenous transforming growth factor beta 1 suppresses inflammation and promotes survival in adult CNS. Journal of Neuroscience, 27, 11201–11213.
Malipiero, U. V., Frei, K., & Fontana, A. (1990). Production of hemopoietic colony-stimulating factors by astrocytes. Journal of Immunology, 144, 3816–3821.
Mana, P., Linares, D., Fordham, S., Staykova, M., & Willenborg, D. (2006). Deleterious role of IFNgamma in a toxic model of central nervous system demyelination. American Journal of Pathology, 168, 1464–1473.
Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M. P., Maggi, E., Trinchieri, G., et al. (1993). Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. Journal of Experimental Medicine, 177, 1199–1204.
Mangan, P. R., Harrington, L. E., O’Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., et al. (2006). Transforming growth factor-beta induces development of the T(H)17 lineage. Nature, 441, 231–234.
Mannie, M. D., Abbott, D. J., & Blanchfield, J. L. (2009). Experimental autoimmune encephalomyelitis in Lewis rats: IFN-beta acts as a tolerogenic adjuvant for induction of neuroantigen-dependent tolerance. Journal of Immunology, 182, 5331–5341.
Marik, C., Felts, P. A., Bauer, J., Lassmann, H., & Smith, K. J. (2007). Lesion genesis in a subset of patients with multiple sclerosis: A role for innate immunity? Brain, 130, 2800–2815.
Markowitz, C. E. (2007). Interferon-beta: Mechanism of action and dosing issues. Neurology, 68, S8–S11.
Marriott, M. P., Emery, B., Cate, H. S., Binder, M. D., Kemper, D., Wu, Q., et al. (2008). Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair. Glia, 56, 686–698.
Martin, D., Near, S. L., Bendele, A., & Russell, D. A. (1995). Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein. Experimental Neurology, 131, 221–228.
Marusic, S., Miyashiro, J. S., Douhan, J., 3rd, Konz, R. F., Xuan, D., Pelker, J. W., et al. (2002). Local delivery of granulocyte macrophage colony-stimulating factor by retrovirally transduced antigen-specific T cells leads to severe, chronic experimental autoimmune encephalomyelitis in mice. Neuroscience Letters, 332, 185–189.
Mason, J. L., Suzuki, K., Chaplin, D. D., & Matsushima, G. K. (2001). Interleukin-1beta promotes repair of the CNS. Journal of Neuroscience, 21, 7046–7052.
Mason, J. L., Xuan, S., Dragatsis, I., Efstratiadis, A., & Goldman, J. E. (2003). Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. Journal of Neuroscience, 23, 7710–7718.
Matthews, A. E., Weiss, S. R., & Paterson, Y. (2002). Murine hepatitis virus—A model for virus-induced CNS demyelination. Journal of Neurovirology, 8, 76–85.
McGuinness, M. C., Powers, J. M., Bias, W. B., Schmeckpeper, B. J., Segal, A. H., Gowda, V. C., et al. (1997). Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis. Journal of Neuroimmunology, 75, 174–182.
McMahan, C. J., Slack, J. L., Mosley, B., Cosman, D., Lupton, S. D., Brunton, L. L., et al. (1991). A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO Journal, 10, 2821–2832.
McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H., & Miller, S. D. (2005). Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nature Medicine, 11, 335–339.
McMahon, E. J., Suzuki, K., & Matsushima, G. K. (2002). Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier. Journal of Neuroimmunology, 130, 32–45.
McQualter, J. L., Darwiche, R., Ewing, C., Onuki, M., Kay, T. W., Hamilton, J. A., et al. (2001). Granulocyte macrophage colony-stimulating factor: A new putative therapeutic target in multiple sclerosis. Journal of Experimental Medicine, 194, 873–882.
Melaragno, M. G., Cavet, M. E., Yan, C., Tai, L. K., Jin, Z. G., Haendeler, J., et al. (2004). Gas6 inhibits apoptosis in vascular smooth muscle: Role of Axl kinase and Akt. Journal of Molecular and Cellular Cardiology, 37, 881–887.
Merrill, J. E. (1991). Effects of interleukin-1 and tumor necrosis factor-alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Developmental Neuroscience, 13, 130–137.
Miller, A., Lider, O., Roberts, A. B., Sporn, M. B., & Weiner, H. L. (1992). Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proceedings of the National Academy of Sciences of the United States of America, 89, 421–425.
Miller, S. D., Vanderlugt, C. L., Begolka, W. S., Pao, W., Yauch, R. L., Neville, K. L., et al. (1997). Persistent infection with Theiler’s virus leads to CNS autoimmunity via epitope spreading. Nature Medicine, 3, 1133–1136.
Mirshafiey, A., & Mohsenzadegan, M. (2009). TGF-beta as a promising option in the treatment of multiple sclerosis. Neuropharmacology, 56, 929–936.
Mitrasinovic, O. M., Perez, G. V., Zhao, F., Lee, Y. L., Poon, C., & Murphy, G. M., Jr. (2001). Overexpression of macrophage colony-stimulating factor receptor on microglial cells induces an inflammatory response. Journal of Biological Chemistry, 276, 30142–30149.
Mitrasinovic, O. M., Vincent, V. A., Simsek, D., & Murphy, G. M., Jr. (2003). Macrophage colony stimulating factor promotes phagocytosis by murine microglia. Neuroscience Letters, 344, 185–188.
Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., & Nagata, S. (2007). Identification of Tim4 as a phosphatidylserine receptor. Nature, 450, 435–439.
Mizuno, T., Sawada, M., Marunouchi, T., & Suzumura, A. (1994). Production of interleukin-10 by mouse glial cells in culture. Biochemical and Biophysical Research Communications, 205, 1907–1915.
Mondal, S., Roy, A., & Pahan, K. (2009). Functional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitis. Journal of Immunology, 182, 5013–5023.
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O’Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology, 19, 683–765.
Morell, P., Barrett, C. V., Mason, J. L., Toews, A. D., Hostettler, J. D., Knapp, G. W., et al. (1998). Gene expression in brain during cuprizone-induced demyelination and remyelination. Molecular and Cellular Neurosciences, 12, 220–227.
Morishima, N., Mizoguchi, I., Takeda, K., Mizuguchi, J., & Yoshimoto, T. (2009). TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23. Biochemical and Biophysical Research Communications, 386, 105–110.
Mosmann, T. R., & Coffman, R. L. (1989). TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology, 7, 145–173.
Mosser, D. M., & Zhang, X. (2008). Interleukin-10: New perspectives on an old cytokine. Immunological Reviews, 226, 205–218.
MS/MRI Analysis Group. (1999). TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology, 53, 457–465.
Mujtaba, M. G., Flowers, L. O., Patel, C. B., Patel, R. A., Haider, M. I., & Johnson, H. M. (2005). Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic. Journal of Immunology, 175, 5077–5086.
Murray, P. J. (2006). Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Current Opinion in Pharmacology, 6, 379–386.
Nakamura, Y. (2002). Regulating factors for microglial activation. Biological and Pharmaceutical Bulletin, 25, 945–953.
Nakano, T., Ishimoto, Y., Kishino, J., Umeda, M., Inoue, K., Nagata, K., et al. (1997). Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. Journal of Biological Chemistry, 272, 29411–29414.
Nakayama, T., & Yamashita, M. (2008). Initiation and maintenance of Th2 cell identity. Current Opinion in Immunology, 20, 265–271.
Navikas, V., Matusevicius, D., Soderstrom, M., Fredrikson, S., Kivisakk, P., Ljungdahl, A., et al. (1996). Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. Journal of Neuroimmunology, 64, 63–69.
Neumann, H., Kotter, M. R., & Franklin, R. J. (2009). Debris clearance by microglia: An essential link between degeneration and regeneration. Brain, 132, 288–295.
Nguyen, V. T., & Benveniste, E. N. (2000). IL-4-activated STAT-6 inhibits IFN-gamma-induced CD40 gene expression in macrophages/microglia. Journal of Immunology, 165, 6235–6243.
Nicoletti, F., Di Marco, R., Patti, F., Reggio, E., Nicoletti, A., Zaccone, P., et al. (1998). Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b). Clinical and Experimental Immunology, 113, 96–99.
Nishiyama, A., Yu, M., Drazba, J. A., & Tuohy, V. K. (1997). Normal and reactive NG2 + glial cells are distinct from resting and activated microglia. Journal of Neuroscience Research, 48, 299–312.
Nowak, E. C., Weaver, C. T., Turner, H., Begum-Haque, S., Becher, B., Schreiner, B., et al. (2009). IL-9 as a mediator of Th17-driven inflammatory disease. Journal of Experimental Medicine, 206, 1653–1660.
O’Brien, K., Fitzgerald, D. C., Naiken, K., Alugupalli, K. R., Rostami, A. M., & Gran, B. (2008). Role of the innate immune system in autoimmune inflammatory demyelination. Current Medicinal Chemistry, 15, 1105–1115.
O’Connor, R. A., Prendergast, C. T., Sabatos, C. A., Lau, C. W., Leech, M. D., Wraith, D. C., et al. (2008). Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. Journal of Immunology, 181, 3750–3754.
O’Garra, A., & Arai, N. (2000). The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends in Cell Biology, 10, 542–550.
O’Keefe, G. M., Nguyen, V. T., & Benveniste, E. N. (1999). Class II transactivator and class II MHC gene expression in microglia: Modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10. European Journal of Immunology, 29, 1275–1285.
O’Keefe, G. M., Nguyen, V. T., & Benveniste, E. N. (2002). Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases. Journal of Neurovirology, 8, 496–512.
O’Keefe, G. M., Nguyen, V. T., Ping Tang, L. L., & Benveniste, E. N. (2001). IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: Involvement of the suppressors of cytokine signaling-1 protein. Journal of Immunology, 166, 2260–2269.
O’Neill, L. A., & Greene, C. (1998). Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants. Journal of Leukocyte Biology, 63, 650–657.
O’Shea, J. J., Ma, A., & Lipsky, P. (2002). Cytokines and autoimmunity. Nature Reviews Immunology, 2, 37–45.
Okuda, Y., Sakoda, S., Bernard, C. C., Fujimura, H., Saeki, Y., Kishimoto, T., et al. (1998). IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. International Immunology, 10, 703–708.
Okuda, Y., Sakoda, S., Fujimura, H., Saeki, Y., Kishimoto, T., & Yanagihara, T. (1999). IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35–55 induced experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 101, 188–196.
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., & Platsoucas, C. D. (2004). Theiler’s virus infection: A model for multiple sclerosis. Clinical Microbiology Reviews, 17, 174–207.
Pace, L., Rizzo, S., Palombi, C., Brombacher, F., & Doria, G. (2006). Cutting edge: IL-4-induced protection of CD4 + CD25- Th cells from CD4 + CD25 + regulatory T cell-mediated suppression. Journal of Immunology, 176, 3900–3904.
Pahan, K., Sheikh, F. G., Liu, X., Hilger, S., McKinney, M., & Petro, T. M. (2001). Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12 p40 in microglial cells. Journal of Biological Chemistry, 276, 7899–7905.
Panitch, H. S., Hirsch, R. L., Haley, A. S., & Johnson, K. P. (1987). Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet, 1, 893–895.
Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., et al. (2002). A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. Journal of Immunology, 168, 5699–5708.
Pasquini, L. A., Calatayud, C. A., Bertone Una, A. L., Millet, V., Pasquini, J. M., & Soto, E. F. (2007). The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochemical Research, 32, 279–292.
Patani, R., Balaratnam, M., Vora, A., & Reynolds, R. (2007). Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathology and Applied Neurobiology, 33, 277–287.
Patrikios, P., Stadelmann, C., Kutzelnigg, A., Rauschka, H., Schmidbauer, M., Laursen, H., et al. (2006). Remyelination is extensive in a subset of multiple sclerosis patients. Brain, 129, 3165–3172.
Paty, D. W., & Li, D. K. (1993). Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology, 43, 662–667.
Pender, M. P. (1999). Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance. Immunology and Cell Biology, 77, 216–223.
Pender, M. P., Nguyen, K. B., McCombe, P. A., & Kerr, J. F. (1991). Apoptosis in the nervous system in experimental allergic encephalomyelitis. Journal of the Neurological Sciences, 104, 81–87.
Pestka, S., Krause, C. D., & Walter, M. R. (2004). Interferons, interferon-like cytokines, and their receptors. Immunological Reviews, 202, 8–32.
Peterson, J. W., Bo, L., Mork, S., Chang, A., Ransohoff, R. M., & Trapp, B. D. (2002). VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions. Journal of Neuropathology and Experimental Neurology, 61, 539–546.
Pfeffer, K., Matsuyama, T., Kundig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., et al. (1993). Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell, 73, 457–467.
Piccio, L., Buonsanti, C., Mariani, M., Cella, M., Gilfillan, S., Cross, A. H., et al. (2007). Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. European Journal of Immunology, 37, 1290–1301.
Piccirillo, C. A., & Thornton, A. M. (2004). Cornerstone of peripheral tolerance: Naturally occurring CD4+CD25+ regulatory T cells. Trends in Immunology, 25, 374–380.
Platten, M., Ho, P. P., Youssef, S., Fontoura, P., Garren, H., Hur, E. M., et al. (2005). Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science, 310, 850–855.
Ponomarev, E. D., Maresz, K., Tan, Y., & Dittel, B. N. (2007a). CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. Journal of Neuroscience, 27, 10714–10721.
Ponomarev, E. D., Shriver, L. P., Maresz, K., Pedras-Vasconcelos, J., Verthelyi, D., & Dittel, B. N. (2007b). GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. Journal of Immunology, 178, 39–48.
Popko, B., & Baerwald, K. D. (1999). Oligodendroglial response to the immune cytokine interferon gamma. Neurochemical Research, 24, 331–338.
Popovic, N., Schubart, A., Goetz, B. D., Zhang, S. C., Linington, C., & Duncan, I. D. (2002). Inhibition of autoimmune encephalomyelitis by a tetracycline. Annals of Neurology, 51, 215–223.
Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R., & Cho, E. S. (1993). Multiple sclerosis: Remyelination of nascent lesions. Annals of Neurology, 33, 137–151.
Prineas, J. W., & Graham, J. S. (1981). Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Annals of Neurology, 10, 149–158.
Prineas, J. W., Kwon, E. E., Goldenberg, P. Z., Ilyas, A. A., Quarles, R. H., Benjamins, J. A., et al. (1989). Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Laboratory Investigation, 61, 489–503.
Prinz, M., Schmidt, H., Mildner, A., Knobeloch, K. P., Hanisch, U. K., Raasch, J., et al. (2008). Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity, 28, 675–686.
Pullen, L. C., Park, S. H., Miller, S. D., Dal Canto, M. C., & Kim, B. S. (1995). Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler’s virus-induced demyelinating disease. Journal of Immunology, 155, 4497–4503.
Qian, L., Wei, S. J., Zhang, D., Hu, X., Xu, Z., Wilson, B., et al. (2008). Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. Journal of Immunology, 181, 660–668.
Qin, H., Roberts, K. L., Niyongere, S. A., Cong, Y., Elson, C. O., & Benveniste, E. N. (2007). Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia. Journal of Immunology, 179, 5966–5976.
Qin, H., Wilson, C. A., Lee, S. J., & Benveniste, E. N. (2006a). IFN-beta-induced SOCS-1 negatively regulates CD40 gene expression in macrophages and microglia. The FASEB Journal, 20, 985–987.
Qin, H., Wilson, C. A., Roberts, K. L., Baker, B. J., Zhao, X., & Benveniste, E. N. (2006b). IL-10 inhibits lipopolysaccharide-induced CD40 gene expression through induction of suppressor of cytokine signaling-3. Journal of Immunology, 177, 7761–7771.
Quintana, A., Muller, M., Frausto, R. F., Ramos, R., Getts, D. R., Sanz, E., et al. (2009). Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. Journal of Immunology, 183, 2079–2088.
Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., et al. (1994). Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. Journal of Experimental Medicine, 180, 1961–1966.
Racke, M. K., Dhib-Jalbut, S., Cannella, B., Albert, P. S., Raine, C. S., & McFarlin, D. E. (1991). Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. Journal of Immunology, 146, 3012–3017.
Radu, D. L., Noben-Trauth, N., Hu-Li, J., Paul, W. E., & Bona, C. A. (2000). A targeted mutation in the IL-4Ralpha gene protects mice against autoimmune diabetes. Proceedings of the National Academy of Sciences of the United States of America, 97, 12700–12704.
Raine, C. S., & Wu, E. (1993). Multiple sclerosis: Remyelination in acute lesions. Journal of Neuropathology and Experimental Neurology, 52, 199–204.
Ransohoff, R. M., & Perry, V. H. (2009). Microglial physiology: Unique stimuli, specialized responses. Annual Review of Immunology, 27, 119–145.
Re, F., Belyanskaya, S. L., Riese, R. J., Cipriani, B., Fischer, F. R., Granucci, F., et al. (2002). Granulocyte-macrophage colony-stimulating factor induces an expression program in neonatal microglia that primes them for antigen presentation. Journal of Immunology, 169, 2264–2273.
Rentzos, M., Nikolaou, C., Rombos, A., Voumvourakis, K., Segditsa, I., & Papageorgiou, C. (1996). Tumour necrosis factor alpha is elevated in serum and cerebrospinal fluid in multiple sclerosis and inflammatory neuropathies. Journal of Neurology, 243, 165–170.
Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., et al. (1995). Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Annals of Neurology, 37, 82–88.
Rothe, J., Lesslauer, W., Lotscher, H., Lang, Y., Koebel, P., Kontgen, F., et al. (1993). Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature, 364, 798–802.
Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B., & Lemke, G. (2007). TAM receptors are pleiotropic inhibitors of the innate immune response. Cell, 131, 1124–1136.
Rothuizen, L. E., Buclin, T., Spertini, F., Trinchard, I., Munafo, A., Buchwalder, P. A., et al. (1999). Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers. Journal of Neuroimmunology, 99, 131–141.
Rothwell, N. J., & Luheshi, G. N. (2000). Interleukin 1 in the brain: Biology, pathology and therapeutic target. Trends in Neurosciences, 23, 618–625.
Ruddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., et al. (1990). An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. Journal of Experimental Medicine, 172, 1193–1200.
Ruuls, S. R., de Labie, M. C., Weber, K. S., Botman, C. A., Groenestein, R. J., Dijkstra, C. D., et al. (1996). The length of treatment determines whether IFN-beta prevents or aggravates experimental autoimmune encephalomyelitis in Lewis rats. Journal of Immunology, 157, 5721–5731.
Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T. S., & Chen, Y. (1998). IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells. Journal of Immunology, 161, 6480–6486.
Santambrogio, L., Hochwald, G. M., Saxena, B., Leu, C. H., Martz, J. E., Carlino, J. A., et al. (1993). Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor. Journal of Immunology, 151, 1116–1127.
Sather, B. D., Treuting, P., Perdue, N., Miazgowicz, M., Fontenot, J. D., Rudensky, A. Y., et al. (2007). Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. Journal of Experimental Medicine, 204, 1335–1347.
Schiffenbauer, J., Streit, W. J., Butfiloski, E., LaBow, M., Edwards, C., 3rd, & Moldawer, L. L. (2000). The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor. Clinical Immunology, 95, 117–123.
Schluesener, H. J., & Lider, O. (1989). Transforming growth factors beta 1 and beta 2: Cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T cell function. Journal of Neuroimmunology, 24, 249–258.
Schmidt, H., Raasch, J., Merkler, D., Klinker, F., Krauss, S., Bruck, W., et al. (2009). Type I interferon receptor signalling is induced during demyelination while its function for myelin damage and repair is redundant. Experimental Neurology, 216, 306–311.
Schmierer, B., & Hill, C. S. (2007). TGFbeta-SMAD signal transduction: Molecular specificity and functional flexibility. Nat Rev Mol Cell Biol, 8, 970–982.
Schmitz, T., & Chew, L. J. (2008). Cytokines and myelination in the central nervous system. Scientific World Journal, 8, 1119–1147.
Schonrock, L. M., Gawlowski, G., & Bruck, W. (2000). Interleukin-6 expression in human multiple sclerosis lesions. Neuroscience Letters, 294, 45–48.
Scolding, N., Franklin, R., Stevens, S., Heldin, C. H., Compston, A., & Newcombe, J. (1998). Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain, 121(Pt 12), 2221–2228.
Scutera, S., Fraone, T., Musso, T., Cappello, P., Rossi, S., Pierobon, D., et al. (2009). Survival and migration of human dendritic cells are regulated by an IFN-alpha-inducible Axl/Gas6 pathway. Journal of Immunology, 183, 3004–3013.
Sebire, G., Emilie, D., Wallon, C., Hery, C., Devergne, O., Delfraissy, J. F., et al. (1993). In vitro production of IL-6, IL-1 beta, and tumor necrosis factor-alpha by human embryonic microglial and neural cells. Journal of Immunology, 150, 1517–1523.
Segal, B. M., Constantinescu, C. S., Raychaudhuri, A., Kim, L., Fidelus-Gort, R., & Kasper, L. H. (2008). Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: A phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurology, 7, 796–804.
Segal, B. M., Dwyer, B. K., & Shevach, E. M. (1998). An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. Journal of Experimental Medicine, 187, 537–546.
Selmaj, K. W., & Raine, C. S. (1988). Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Annals of Neurology, 23, 339–346.
Selmaj, K. W., & Raine, C. S. (1995). Experimental autoimmune encephalomyelitis: Immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology, 45, S44–S49.
Selmaj, K., Raine, C. S., & Cross, A. H. (1991). Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Annals of Neurology, 30, 694–700.
Selvaraju, R., Bernasconi, L., Losberger, C., Graber, P., Kadi, L., Avellana-Adalid, V., et al. (2004). Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Molecular and Cellular Neurosciences, 25, 707–721.
Serada, S., Fujimoto, M., Mihara, M., Koike, N., Ohsugi, Y., Nomura, S., et al. (2008). IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America, 105, 9041–9046.
Setzu, A., Lathia, J. D., Zhao, C., Wells, K., Rao, M. S., Ffrench-Constant, C., et al. (2006). Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia, 54, 297–303.
Shankar, S. L., O’Guin, K., Cammer, M., McMorris, F. A., Stitt, T. N., Basch, R. S., et al. (2003). The growth arrest-specific gene product Gas6 promotes the survival of human oligodendrocytes via a phosphatidylinositol 3-kinase-dependent pathway. Journal of Neuroscience, 23, 4208–4218.
Shankar, S. L., O’Guin, K., Kim, M., Varnum, B., Lemke, G., Brosnan, C. F., et al. (2006). Gas6/Axl signaling activates the phosphatidylinositol 3-kinase/Akt1 survival pathway to protect oligodendrocytes from tumor necrosis factor alpha-induced apoptosis. Journal of Neuroscience, 26, 5638–5648.
Sharif, M. N., Sosic, D., Rothlin, C. V., Kelly, E., Lemke, G., Olson, E. N., et al. (2006). Twist mediates suppression of inflammation by type I IFNs and Axl. Journal of Experimental Medicine, 203, 1891–1901.
Shaw, M. K., Lorens, J. B., Dhawan, A., DalCanto, R., Tse, H. Y., Tran, A. B., et al. (1997). Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. Journal of Experimental Medicine, 185, 1711–1714.
Sheehan, K. C., Pinckard, J. K., Arthur, C. D., Dehner, L. P., Goeddel, D. V., & Schreiber, R. D. (1995). Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: Identification of a novel in vivo role for p75. Journal of Experimental Medicine, 181, 607–617.
Shevach, E. M. (2000). Regulatory T cells in autoimmmunity. Annual Review of Immunology, 18, 423–449.
Shields, S., Gilson, J., Blakemore, W., & Franklin, R. (2000). Remyelination occurs as extensively but more slowly in old rats compared to young rats following fliotoxin-induced CNS demyelination. Glia, 29, 102.
Shinohara, M. L., Kim, J. H., Garcia, V. A., & Cantor, H. (2008). Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: Role of intracellular osteopontin. Immunity, 29, 68–78.
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., et al. (1992). Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature, 359, 693–699.
Smith, M. E. (1999). Phagocytosis of myelin in demyelinative disease: A review. Neurochemical Research, 24, 261–268.
Smith, M. E., van der Maesen, K., & Somera, F. P. (1998). Macrophage and microglial responses to cytokines in vitro: Phagocytic activity, proteolytic enzyme release, and free radical production. Journal of Neuroscience Research, 54, 68–78.
Soh, J., Donnelly, R. J., Kotenko, S., Mariano, T. M., Cook, J. R., Wang, N., et al. (1994). Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor. Cell, 76, 793–802.
Soldan, S. S., Alvarez Retuerto, A. I., Sicotte, N. L., & Voskuhl, R. R. (2004). Dysregulation of IL-10 and IL-12p40 in secondary progressive multiple sclerosis. Journal of Neuroimmunology, 146, 209–215.
Sonobe, Y., Liang, J., Jin, S., Zhang, G., Takeuchi, H., Mizuno, T., et al. (2008). Microglia express a functional receptor for interleukin-23. Biochemical and Biophysical Research Communications, 370, 129–133.
Sonobe, Y., Yawata, I., Kawanokuchi, J., Takeuchi, H., Mizuno, T., & Suzumura, A. (2005). Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Research, 1040, 202–207.
Sospedra, M., & Martin, R. (2005). Immunology of multiple sclerosis. Annual Review of Immunology, 23, 683–747.
Staykova, M. A., Berven, L. A., Cowden, W. B., Willenborg, D. O., & Crouch, M. F. (2003). Nitric oxide induces polarization of actin in encephalitogenic T cells and inhibits their in vitro trans-endothelial migration in a p70S6 kinase-independent manner. The FASEB Journal, 17, 1337–1339.
Steinman, L., & Zamvil, S. S. (2005). Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends in Immunology, 26, 565–571.
Stevens, D. B., Gould, K. E., & Swanborg, R. H. (1994). Transforming growth factor-beta 1 inhibits tumor necrosis factor-alpha/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis. Journal of Neuroimmunology, 51, 77–83.
Stumhofer, J. S., Laurence, A., Wilson, E. H., Huang, E., Tato, C. M., Johnson, L. M., et al. (2006). Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nature Immunology, 7, 937–945.
Sugiura, S., Lahav, R., Han, J., Kou, S. Y., Banner, L. R., de Pablo, F., et al. (2000). Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. European Journal of Neuroscience, 12, 457–466.
Suzumura, A., Sawada, M., Yamamoto, H., & Marunouchi, T. (1993). Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. Journal of Immunology, 151, 2150–2158.
Takahashi, K., Prinz, M., Stagi, M., Chechneva, O., & Neumann, H. (2007). TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Medicine, 4, e124.
Takeda, A., Hamano, S., Yamanaka, A., Hanada, T., Ishibashi, T., Mak, T. W., et al. (2003). Cutting edge: Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. Journal of Immunology, 170, 4886–4890.
Takeuchi, A., Miyaishi, O., Kiuchi, K., & Isobe, K. (2001). Macrophage colony-stimulating factor is expressed in neuron and microglia after focal brain injury. Journal of Neuroscience Research, 65, 38–44.
Taniguchi, T., & Takaoka, A. (2001). A weak signal for strong responses: Interferon-alpha/beta revisited. Nature Reviews. Molecular Cell Biology, 2, 378–386.
Tansey, M. G., & Wyss-Coray, T. (2008). Cytokines in CNS Inflammation and Disease. In T. E. Lane, M. Carson, C. Bergman, & T. Wyss-Coray (Eds.), Central nervous system diseases and inflammation (pp. 59–106). Heidelberg: Springer.
Tartaglia, L. A., Goeddel, D. V., Reynolds, C., Figari, I. S., Weber, R. F., Fendly, B. M., et al. (1993). Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. Journal of Immunology, 151, 4637–4641.
Teige, I., Liu, Y., & Issazadeh-Navikas, S. (2006). IFN-beta inhibits T cell activation capacity of central nervous system APCs. Journal of Immunology, 177, 3542–3553.
Teige, I., Treschow, A., Teige, A., Mattsson, R., Navikas, V., Leanderson, T., et al. (2003). IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. Journal of Immunology, 170, 4776–4784.
Tenorio, E., & Mack, D. M. (2008). Therapeutic anti-inflammatory mechanism of action of Type I interferons. Bioscience Hypotheses, 1, 218–222.
Thakker, P., Leach, M. W., Kuang, W., Benoit, S. E., Leonard, J. P., & Marusic, S. (2007). IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. Journal of Immunology, 178, 2589–2598.
‘t Hart, B. A., Brok, H. P., Remarque, E., Benson, J., Treacy, G., Amor, S., et al. (2005). Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human-anti-human IL-12p40 antibody. Journal of Immunology, 175, 4761–4768.
Theofilopoulos, A. N., Baccala, R., Beutler, B., & Kono, D. H. (2005). Type I interferons (alpha/beta) in immunity and autoimmunity. Annual Review of Immunology, 23, 307–336.
Thomas, K. E., Galligan, C. L., Newman, R. D., Fish, E. N., & Vogel, S. N. (2006). Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide. Journal of Biological Chemistry, 281, 31119–31130.
Toshchakov, V., Jones, B. W., Perera, P. Y., Thomas, K., Cody, M. J., Zhang, S., et al. (2002). TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nature Immunology, 3, 392–398.
Totoiu, M. O., Nistor, G. I., Lane, T. E., & Keirstead, H. S. (2004). Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis. Experimental Neurology, 187, 254–265.
Tran, E. H., Prince, E. N., & Owens, T. (2000). IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. Journal of Immunology, 164, 2759–2768.
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mork, S., & Bo, L. (1998). Axonal transection in the lesions of multiple sclerosis. New England Journal of Medicine, 338, 278–285.
Trapp, B. D., Ransohoff, R., & Rudick, R. (1999). Axonal pathology in multiple sclerosis: Relationship to neurologic disability. Current Opinion in Neurology, 12, 295–302.
Trebst, C., Heine, S., Lienenklaus, S., Lindner, M., Baumgartner, W., Weiss, S., et al. (2007). Lack of interferon-beta leads to accelerated remyelination in a toxic model of central nervous system demyelination. Acta Neuropathologica, 114, 587–596.
Trinchieri, G. (2003). Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nature Reviews Immunology, 3, 133–146.
Tsukada, N., Miyagi, K., Matsuda, M., Yanagisawa, N., & Yone, K. (1991). Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. Journal of the Neurological Sciences, 104, 230–234.
Ulrich, R., Seeliger, F., Kreutzer, M., Germann, P. G., & Baumgärtner, W. (2008). Limited remyelination in Theiler’s murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells. Neuropathology and Applied Neurobiology, 34, 603–620.
van Oosten, B. W., Barkhof, F., Truyen, L., Boringa, J. B., Bertelsmann, F. W., von Blomberg, B. M., et al. (1996). Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology, 47, 1531–1534.
Van Ostade, X., Vandenabeele, P., Everaerdt, B., Loetscher, H., Gentz, R., Brockhaus, M., et al. (1993). Human TNF mutants with selective activity on the p55 receptor. Nature, 361, 266–269.
Vandenabeele, P., Declercq, W., Beyaert, R., & Fiers, W. (1995). Two tumour necrosis factor receptors: Structure and function. Trends in Cell Biology, 5, 392–399.
Vargas, M. E., & Barres, B. A. (2007). Why is Wallerian degeneration in the CNS so slow? Annual Review of Neuroscience, 30, 153–179.
Vela, J. M., Molina-Holgado, E., Arevalo-Martin, A., Almazan, G., & Guaza, C. (2002). Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Molecular and Cellular Neurosciences, 20, 489–502.
Veldhoen, M., Hocking, R. J., Flavell, R. A., & Stockinger, B. (2006). Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nature Immunology, 7, 1151–1156.
Villarroya, H., Violleau, K., Ben Younes-Chennoufi, A., & Baumann, N. (1996). Myelin-induced experimental allergic encephalomyelitis in Lewis rats: Tumor necrosis factor alpha levels in serum and cerebrospinal fluid immunohistochemical expression in glial cells and macrophages of optic nerve and spinal cord. Journal of Neuroimmunology, 64, 55–61.
von Zahn, J., Moller, T., Kettenmann, H., & Nolte, C. (1997). Microglial phagocytosis is modulated by pro- and anti-inflammatory cytokines. Neuroreport, 8, 3851–3856.
Waetzig, V., Czeloth, K., Hidding, U., Mielke, K., Kanzow, M., Brecht, S., et al. (2005). c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia, 50, 235–246.
Wahl, S. M. (1994). Transforming growth factor beta: The good, the bad, and the ugly. Journal of Experimental Medicine, 180, 1587–1590.
Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N., Wahl, L. M., Roberts, A. B., et al. (1987). Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proceedings of the National Academy of Sciences of the United States of America, 84, 5788–5792.
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003). Tumor necrosis factor signaling. Cell Death and Differentiation, 10, 45–65.
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. P. (1999). Tumor necrosis factor receptor and Fas signaling mechanisms. Annual Review of Immunology, 17, 331–367.
Wang, J., Asensio, V. C., & Campbell, I. L. (2002). Cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice. Current Topics in Microbiology and Immunology, 265, 23–48.
Wang, Z., Hong, J., Sun, W., Xu, G., Li, N., Chen, X., et al. (2006). Role of IFN-gamma in induction of Foxp3 and conversion of CD4 + CD25- T cells to CD4 + Tregs. Journal of Clinical Investigation, 116, 2434–2441.
Wang, Y., Lawson, M. A., Dantzer, R., & Kelley, K. W. (2010). LPS-induced indoleamine 2, 3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia. Brain, Behavior, and Immunity, 24, 201–209.
Wei, R., & Jonakait, G. M. (1999). Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-beta1 (TGF-beta1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia. Journal of Neuroimmunology, 95, 8–18.
Weinger, J. G., Omari, K. M., Marsden, K., Raine, C. S., & Shafit-Zagardo, B. (2009). Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions. American Journal of Pathology, 175, 283–293.
Weinstock-Guttman, B., Ramanathan, M., & Zivadinov, R. (2008). Interferon-beta treatment for relapsing multiple sclerosis. Expert Opinion on Biological Therapy, 8, 1435–1447.
Wesche, H., Henzel, W. J., Shillinglaw, W., Li, S., & Cao, Z. (1997). MyD88: An adapter that recruits IRAK to the IL-1 receptor complex. Immunity, 7, 837–847.
Wesemann, D. R., Dong, Y., O’Keefe, G. M., Nguyen, V. T., & Benveniste, E. N. (2002). Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages. Journal of Immunology, 169, 2354–2360.
Williams, K., Dooley, N., Ulvestad, E., Becher, B., & Antel, J. P. (1996). IL-10 production by adult human derived microglial cells. Neurochemistry International, 29, 55–64.
Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M. N., Cuzner, M. L., et al. (1995). Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. Journal of Experimental Medicine, 182, 1985–1996.
Wirjatijasa, F., Dehghani, F., Blaheta, R. A., Korf, H. W., & Hailer, N. P. (2002). Interleukin-4, interleukin-10, and interleukin-1-receptor antagonist but not transforming growth factor-beta induce ramification and reduce adhesion molecule expression of rat microglial cells. Journal of Neuroscience Research, 68, 579–587.
Wolf, S. F., Temple, P. A., Kobayashi, M., Young, D., Dicig, M., Lowe, L., et al. (1991). Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. Journal of Immunology, 146, 3074–3081.
Wolswijk, G. (2002). Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain, 125, 338–349.
Xiao, B. G., Bai, X. F., Zhang, G. X., Hojeberg, B., & Link, H. (1996). Shift from anti- to proinflammatory cytokine profiles in microglia through LPS- or IFN-gamma-mediated pathways. Neuroreport, 7, 1893–1898.
Xiao, B. G., Ma, C. G., Xu, L. Y., Link, H., & Lu, C. Z. (2008). IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis. Molecular Immunology, 45, 1191–1196.
Yadav, M. C., Burudi, E. M., Alirezaei, M., Flynn, C. C., Watry, D. D., Lanigan, C. M., et al. (2007). IFN-gamma-induced IDO and WRS expression in microglia is differentially regulated by IL-4. Glia, 55, 1385–1396.
Yaguchi, M., Ohta, S., Toyama, Y., Kawakami, Y., & Toda, M. (2008). Functional recovery after spinal cord injury in mice through activation of microglia and dendritic cells after IL-12 administration. Journal of Neuroscience Research, 86, 1972–1980.
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., et al. (2003a). Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science, 301, 640–643.
Yamamoto, M., Sato, S., Hemmi, H., Uematsu, S., Hoshino, K., Kaisho, T., et al. (2003b). TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nature Immunology, 4, 1144–1150.
Yan, H., & Rivkees, S. (2002). Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. Journal of Neuroscience Research, 69, 597–606.
Yoshimura, A. (2005). Negative regulation of cytokine signaling. Clinical Reviews in Allergy and Immunology, 28, 205–220.
Young, D. A., Lowe, L. D., Booth, S. S., Whitters, M. J., Nicholson, L., Kuchroo, V. K., et al. (2000). IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. Journal of Immunology, 164, 3563–3572.
Yu, M., Nishiyama, A., Trapp, B. D., & Tuohy, V. K. (1996). Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 64, 91–100.
Zhang, B., Harness, J., Somodevilla-Torres, M. J., Hillyard, N. C., Mould, A. W., Alewood, D., et al. (2000). Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139–151. Journal of the Neurological Sciences, 182, 5–15.
Zhao, C., Fancy, S. P., ffrench-Constant, C., & Franklin, R. J. (2008). Osteopontin is extensively expressed by macrophages following CNS demyelination but has a redundant role in remyelination. Neurobiology of Diseases, 31, 209–217.
Zhao, W., Xie, W., Xiao, Q., Beers, D. R., & Appel, S. H. (2006). Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia. Journal of Neurochemistry, 99, 1176–1187.
Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H., & Lenardo, M. J. (1995). Induction of apoptosis in mature T cells by tumour necrosis factor. Nature, 377, 348–351.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Merson, T.D., Binder, M.D. & Kilpatrick, T.J. Role of Cytokines as Mediators and Regulators of Microglial Activity in Inflammatory Demyelination of the CNS. Neuromol Med 12, 99–132 (2010). https://doi.org/10.1007/s12017-010-8112-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-010-8112-z